BioSilver-CEP formulation ready for testing in Adhya BioScience Lab.
QuickGun LifeScience is developing a patent pending formulation as an alternative to fast track Covid-19 vaccine program ANI | Updated: Dec 11, 2020 13:04 IST
New Delhi [India], December 11 (ANI/SRV Media): The need for a preventive and curative vaccine to combat the growing Covid-19 virus is the need of the hour.With over 170 countries around the world in a race to develop the first vaccine for coronavirus, researchers and scientists are treading the path, not without challenges.
A critical review of vaccine technologies is as follows:
Inactivated viral vaccine approach: Research was conducted on ferrets and nonhuman primates and a virus-like-particle vaccine on mice induced protection against the SARS-COV. However, the challenged animals exhibited an immunopathologic-type lung disease
QuickGun LifeScience developing patent pending formulation bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.